Synkoloid Company Asbestos Trust fund, created with $21.2 million, pays people diagnosed with mesothelioma from its joint compound and other construction products. Lawsuits stemming from the products forced two companies that acquired it into bankruptcy.
Quick Facts About Synkoloid Company (ARTRA) Trust Fund and Lawsuits
Founded:
1894
Years Operated:
1894 — Present
Headquarters:
Bayonne, New Jersey
Business:
Painting, patching and wood finishing supplies
Asbestos Trust:
Yes
Bankruptcy Status:
Filed May 20, 2003, and reorganized Jan. 24, 2007
What Is the Synkoloid Company Asbestos Trust
The Synkoloid Company asbestos trust was created after the previous owners, Muralo and ARTRA Group reorganized in 2007. The ARTRA Group had acquired Synkoloid Company in 1975. Six years later, Muralo Company Inc. purchased the majority of Synkoloid Company’s assets and agreed to assume any future claims against Synkoloid.
However, it refused to take responsibility for any products manufactured before 1981. Because Muralo didn’t use asbestos in any products, the asbestos lawsuits fell to ARTRA. ARTRA continued to take on the suits until it filed for bankruptcy protection in 2002.
ARTRA Asbestos Trust Updates
The current payment percentage is 0.70%.
Mesothelioma has a scheduled payment of $275,000.
Lung cancer has a scheduled payment of $40,000.
Other cancers have a scheduled payment of $10,000.
After ARTRA went bankrupt, plaintiffs began suing Muralo for Synkoloid product injuries. Because of its small size, Muralo was unable to defend itself against the flow of lawsuits and filed for bankruptcy protection in 2003, which is when it created its asbestos trust fund. By then, the company had been named as a defendant in more than 60,000 asbestos-related lawsuits stemming from Synkoloid products.
Both ARTRA and Muralo reorganized in 2007. As part of a settlement between the 2 companies, Muralo’s insurers contributed $2.5 million to the ARTRA Asbestos Trust, which works to settle all asbestos lawsuits against the Synkoloid Company.
Legal Help for People Exposed to Synkoloid Company Asbestos Products
Workers who handled Synkoloid’s asbestos joint compounds and later developed mesothelioma or other asbestos diseases gain real advantages from skilled legal help. A mesothelioma lawyer assists claimants by documenting exposure history, collecting job records and medical proof and filing full claims to the ARTRA Asbestos Trust before deadlines pass.
Many workers encountered asbestos products from several manufacturers during their careers, so an experienced asbestos attorney digs into your full work history. This full check finds all companies whose items caused your exposure, which matters because some firms never went bankrupt and remain open to direct mesothelioma lawsuits. Your attorney handles trust claims and possible court actions together, making sure one payment source counts right toward others when rules demand it. Our Patient Advocates connect you to these experts who know Synkoloid claims inside out.
Were You Exposed to Asbestos Products Made by Synkoloid?
Gain access to trust funds, grants and other forms of compensation for you or your loved ones.
Lawsuits involving Synkoloid’s asbestos products have been filed by plaintiffs diagnosed with asbestosis, mesothelioma and lung cancer. In 2002, John Henry Pace filed a lawsuit against Synkoloid for damages after being diagnosed with asbestosis. Pace was a self-employed contractor throughout the 1960s and early 1970s. During this time, he often used the company’s asbestos-containing product line, specifically Synkoloid Triple Duty Joint Compound.
Synkoloid began making the asbestos-containing joint compound in 1949, and in 1969, a supplier informed the company of the deadly health effects of asbestos. Despite the new information, Synkoloid continued manufacturing the product with asbestos until 1975. Pace won his case and was awarded more than $2 million for medical expenses and mental and physical suffering.
Synkoloid’s History With Asbestos
Synkoloid Company made paints, varnishes, adhesives and asphalts in New Jersey from 1949 to 1976. Those products contained high levels of asbestos that exposed workers to serious health risks over time.
ARTRA Group took over in 1975. Lawsuits began in 1962 and accumulated rapidly. ARTRA defended 46,000 cases by 2000. Muralo Company bought most of its assets in 1981 and handled new claims. Muralo didn’t take responsibility for any old products made before 1981.
Muralo kept Synkoloid as a division until 2014. California Products Corporation then bought those holdings. Synkoloid no longer operates. California sells Synkoloid-brand goods without asbestos today.
Occupations at Risk of Exposure to Synkoloid’s Asbestos Products
Synkoloid actively marketed its products to painting contractors, carpenters, drywall finishers and plasterers. Because of this targeting, workers in the construction industry used the company’s products most frequently.
Higher Risk Jobs
Carpenters
Construction workers
Drywall workers
Maintenance workers
Inspectors
Painters
Plasterers
Plumbers
Synkoloid Company stopped using asbestos in its products in 1975. Older homes and buildings may still contain Synkoloid products with asbestos.
Synkoloid’s Asbestos Products
Synkoloid Company made many construction products that workers used on walls, roofs and joints. These items contained asbestos fibers that became dangerous when sanded or mixed.
Synkoloid Asbestos-Containing Products
Cement Patch Tex-Add
EZE-Tex Texture
Flexi-Patch
Kool-Kap Roof Coating
Plastibond
Prime ’N Fill
Snohide
Stucco ’N Cement Patch
Surface Conditioner
Synkoloid Triple Duty Joint Compound
Synko-Topping Triple Duty Joint Compound
Tex-Wall
Vinyl Prep Mix
Vinyl Tex-Wall Surface Condition Paste
People who used these asbestos-containing products face higher risks of mesothelioma and lung diseases over time. Buildings with these products still need careful checks during repairs today.
Recommended Reading
Address
1 S. Orange Ave., Suite 301, Orlando, FL 32801
Connect with us
Navigation
Monthly Newsletter
Stay up-to-date on treatment, research, clinical trials, doctors and survivors
The information on this website is proprietary and protected. It is not a substitute for professional medical advice, diagnosis or treatment. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our privacy policy and terms of service for more information about our website.
This website and its content may be deemed attorney advertising. Prior results do not predict a similar outcome.
The Mesothelioma Center’s claim as the most trusted resource is based on our more than 150 5-star Google and BBB reviews. Our organization also helps more than half of all mesothelioma patients annually diagnosed.
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
Fact Checked
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Reviewed
Asbestos.com is the nation’s most trusted mesothelioma resource
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
About The Mesothelioma Center at Asbestos.com
Assisting mesothelioma patients and their loved ones since 2006.
Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
A+ rating from the Better Business Bureau.
5-star reviewed mesothelioma and support organization.
My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.
Whitmer, M. (2026, January 21). Synkoloid Company (ARTRA) Trust Fund and Lawsuits. Asbestos.com. Retrieved January 27, 2026, from https://www.asbestos.com/companies/synkoloid-company/
MLA
Whitmer, Michelle. "Synkoloid Company (ARTRA) Trust Fund and Lawsuits." Asbestos.com, 21 Jan 2026, https://www.asbestos.com/companies/synkoloid-company/.
Chicago
Whitmer, Michelle. "Synkoloid Company (ARTRA) Trust Fund and Lawsuits." Asbestos.com. Last modified January 21, 2026. https://www.asbestos.com/companies/synkoloid-company/.
D. Carl Money is an attorney at Nemeroff Law. He has devoted his career to fighting for workers diagnosed with mesothelioma and their families. Money has more than 25 years of experience fighting for people with asbestos-related diseases. He’s licensed in Texas, New York, England and Wales and belongs to various legal organizations across the U.S. and U.K.
Fact-checked and verified content:
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Please read our editorial guidelines to learn more about our content creation and review process.